.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
India currently faces a massive gap in healthcare where less than 1% of patients receive essential end-of-life support. Consequently, the Indian Council of Medical Research (ICMR) is initiating a landmark multi-state study to expand palliative care access India. This implementation research targets the public health system to provide relief for those with serious chronic illnesses. Furthermore, the program focuses on conditions like cancer, advanced neurological disorders, and chronic respiratory diseases. However, current statistics show that 6.21 per 1,000 people in India require these services immediately. Therefore, the ICMR study will evaluate models across district hospitals and primary health centers to bridge this divide.
The demand for specialized end-of-life care is rising sharply due to an aging population and non-communicable diseases. Additionally, the World Health Organization predicts an 87% increase in serious health-related suffering by 2060. Specifically, rural areas and elderly populations face the highest burden of unaddressed pain. Because of limited trained personnel and regulatory barriers, most families suffer significant financial and emotional strain. Moreover, the lack of home-based options often leads to high out-of-pocket expenses. This ICMR initiative aims to test scalable models that integrate palliative care into routine medical services. Finally, successful integration could lower hospitalization rates and improve the quality of life for millions of Indian citizens.
Q1: Why is palliative care access India currently so limited?
Access remains low due to a shortage of trained healthcare workers, limited services at the grassroots level, and regulatory hurdles regarding pain management medications.
Q2: What is the primary objective of the ICMR multi-state study?
The study aims to develop and test scalable palliative care models within the existing public health infrastructure, including community health centers and home-based settings.
Q3: How will the study benefit families of patients with chronic illnesses?
By integrating palliative care into routine services, the study hopes to reduce the caregiver burden and lower the high out-of-pocket costs associated with long-term care.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
ICMR launches a multi-state study to expand palliative care access in India, targeting public health systems to reduce suffering and lower healthcare costs....
4 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
